Correlation Between SAB Biotherapeutics and NextCure
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and NextCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and NextCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and NextCure, you can compare the effects of market volatilities on SAB Biotherapeutics and NextCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of NextCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and NextCure.
Diversification Opportunities for SAB Biotherapeutics and NextCure
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between SAB and NextCure is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and NextCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCure and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with NextCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCure has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and NextCure go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and NextCure
Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 3.07 times more return on investment than NextCure. However, SAB Biotherapeutics is 3.07 times more volatile than NextCure. It trades about 0.19 of its potential returns per unit of risk. NextCure is currently generating about -0.28 per unit of risk. If you would invest 266.00 in SAB Biotherapeutics on June 24, 2024 and sell it today you would earn a total of 73.00 from holding SAB Biotherapeutics or generate 27.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
SAB Biotherapeutics vs. NextCure
Performance |
Timeline |
SAB Biotherapeutics |
NextCure |
SAB Biotherapeutics and NextCure Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SAB Biotherapeutics and NextCure
The main advantage of trading using opposite SAB Biotherapeutics and NextCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, NextCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCure will offset losses from the drop in NextCure's long position.SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
NextCure vs. HCW Biologics | NextCure vs. RenovoRx | NextCure vs. Scpharmaceuticals | NextCure vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |